Cargando…

Long‐term follow‐up of implantable cardioverter defibrillator patients with regard to appropriate therapy, complications, and mortality

BACKGROUND: An implantable cardioverter defibrillator (ICD) is recommended for patients with symptomatic heart failure with ejection fraction ≤35% despite optimal medical therapy. More recently, the benefits of ICDs have been questioned in nonischemic cardiomyopathy (CM). AIM: To examine the inciden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mattsson, Gustav, Magnusson, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Devices
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027920/ https://www.ncbi.nlm.nih.gov/pubmed/31891421 http://dx.doi.org/10.1111/pace.13869

Ejemplares similares

Long-Term Follow-Up of Patients with Chronic Chagas Disease and Implantable Cardioverter-Defibrillator
por: Pereira, Francisca Tatiana Moreira, et al.
Publicado: (2014)

Remote monitoring of implantable cardioverter defibrillators: Patient experiences and preferences for follow‐up
por: Timmermans, Ivy, et al.
Publicado: (2019)

Diagnosis and management of subcutaneous implantable cardioverter‐defibrillator infections based on process mapping
por: Baddour, Larry M., et al.
Publicado: (2020)

Impact of the COVID‐19 lockdown on the arrhythmic burden of patients with implantable cardioverter‐defibrillators
por: Sassone, Biagio, et al.
Publicado: (2021)

Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study)
por: Broers, Eva R., et al.
Publicado: (2019)

Appropriate therapy for implantable cardioverter defibrillators used as primary versus secondary prophylaxis
por: Thuraiaiyah, J, et al.
Publicado: (2023)

Sex difference in appropriate shocks but not mortality during long-term follow-up in patients with implantable cardioverter-defibrillators
por: Seegers, Joachim, et al.
Publicado: (2016)

Implantable cardioverter-defibrillator–related procedures and associated complications in continuous flow left ventricular assist device recipients: A multicenter experience
por: Ravichandran, Ashwin, et al.
Publicado: (2021)

Association between implantable cardioverter-defibrillator and survival in patients awaiting heart transplantation: A meta-analysis and systematic review
por: Lin, Andrew Y., et al.
Publicado: (2021)

Renal function and the long‐term clinical outcomes of cardiac resynchronization therapy with or without defibrillation
por: Leyva, Francisco, et al.
Publicado: (2019)

Predictors of primary prevention implantable cardioverter‐defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all‐cause mortality
por: Schrage, Benedikt, et al.
Publicado: (2022)

Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up
por: Gandhi, Kaushang, et al.
Publicado: (2010)

Implantable cardioverter‐defibrillator in Brugada syndrome: Long‐term follow‐up
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2019)

Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience
por: Kutyifa, Valentina, et al.
Publicado: (2014)

Subcutaneous implantable cardioverter-defibrillator generator removal: a multicenter analysis
por: Luker, J, et al.
Publicado: (2023)

Health-related quality of life in patients with implantable cardioverter defibrillators in Sweden: a cross-sectional observational trial
por: Magnusson, Peter, et al.
Publicado: (2021)

Health status measured by Kansas City Cardiomyopathy Questionnaire-12 in primary prevention implantable cardioverter defibrillator patients with heart failure
por: Mattsson, Gustav, et al.
Publicado: (2021)

Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017)

The long‐term outcomes of cardiac implantable electronic devices implanted via the femoral route
por: Griffiths, Samuel, et al.
Publicado: (2022)

Long‐term follow‐up of the two‐incision implantation technique for the subcutaneous implantable cardioverter‐defibrillator
por: van der Stuijt, Willeke, et al.
Publicado: (2020)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Predictors of appropriate ICD therapy in patients with implantable cardioverter-defibrillator
por: Dehghani, Mohammad Reza, et al.
Publicado: (2006)

Pulsed-field ablation in patients with permanent pacemaker or implantable cardioverter defibrillator: Is it safe?
por: Lennerz, C, et al.
Publicado: (2023)

Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria
por: An, Yoshimori, et al.
Publicado: (2017)

Pacemaker and Defibrillator Implantation and Programming in Patients with Deep Brain Stimulation
por: Elliott, Mark, et al.
Publicado: (2019)

Prospective long-term follow-up of silicone-polyurethane–insulated implantable cardioverter-defibrillator leads
por: Cairns, John A., et al.
Publicado: (2021)

Complications and Mortality of Single Versus Dual Chamber Implantable Cardioverter Defibrillators
por: Bagherzadeh, Ataallah, et al.
Publicado: (2006)

Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy
por: Apiyasawat, Sirin, et al.
Publicado: (2014)

Baseline and Dynamic Risk Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy
por: Wu, Katherine C., et al.
Publicado: (2020)

Blood stream infection in patients with implantable-cardioverter defibrillator admitted to non-cardiology units: incidence, diagnostic work-up and outcome
por: Oezkartal, T, et al.
Publicado: (2023)

Impact of Moderate to Severe Renal Impairment on Mortality and Appropriate Shocks in Patients with Implantable Cardioverter Defibrillators
por: Alla, Venkata M., et al.
Publicado: (2010)

Paradox of Appropriate Implantable Cardioverter‐Defibrillator Therapy: Saving Lives But Revealing an Increased Mortality Risk
por: Aleong, Ryan G., et al.
Publicado: (2017)

Long-Term Prognosis of Patients with an Implantable Cardioverter-Defibrillator in Korea
por: Uhm, Jae-Sun, et al.
Publicado: (2017)

Impact of fracture‐prone implantable cardioverter defibrillator leads on long‐term patient mortality
por: Koike, Toshiharu, et al.
Publicado: (2023)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Intraoperative defibrillation threshold testing and postoperative long-term efficacy of cardioverter-defibrillator implantation
por: GAN, TIANYI, et al.
Publicado: (2013)

Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators
por: Burri, Haran, et al.
Publicado: (2009)

Generator and Lead-Related Complications of Implantable Cardioverter Defibrillators
por: Yaminisharif, Ahmad, et al.
Publicado: (2014)

Stability, Survival, and Tolerability of an Auditory Osseointegrated Implant for Bone Conduction Hearing: Long-Term Follow-Up of a Randomized Controlled Trial
por: den Besten, Christine A., et al.
Publicado: (2016)

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
por: van Barreveld, Marit, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v8i1kop9jr3c2iosrmereaunq4